Literature DB >> 1695778

Epidemiology and natural history of benign prostatic hyperplasia.

M J Barry1.   

Abstract

Benign prostatic hyperplasia (BPH) afflicts the majority of elderly men, and if current rates of surgery persist, the average 40-year-old man in the United States will have a 30 to 40 per cent chance of undergoing a prostatectomy if he survives to age 80. Age is by the far the most important determinant of BPH occurrence. Symptomatic BPH has a waxing and waning course, and a few men may have long-term remission. Surprisingly, the natural history of BPH is poorly defined, particularly with regard to the magnitude of the risks of its complications.

Entities:  

Mesh:

Year:  1990        PMID: 1695778

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  28 in total

1.  Thermotherapy still investigational.

Authors:  E W Ramsey
Journal:  CMAJ       Date:  1992-12-15       Impact factor: 8.262

2.  Healthcare practices among blacks and whites with urinary tract symptoms.

Authors:  Daniel L Howard; Bennett G Edwards; Kimberly Whitehead; M Ahinee Amamoo; Paul A Godley
Journal:  J Natl Med Assoc       Date:  2007-04       Impact factor: 1.798

Review 3.  Benign prostatic hyperplasia: dietary and metabolic risk factors.

Authors:  H Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-02-02       Impact factor: 2.370

4.  Underdetection of clinical benign prostatic hyperplasia in a general medical practice.

Authors:  M F Collins; R H Friedman; A Ash; R Hall; M A Moskowitz
Journal:  J Gen Intern Med       Date:  1996-09       Impact factor: 5.128

Review 5.  Alpha 1-blockers vs 5 alpha-reductase inhibitors in benign prostatic hyperplasia. A comparative review.

Authors:  J T Andersen
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

6.  Durability of laser fibers.

Authors:  E te Slaa; A F van Ettergem; C A van 't Hof; F M Debruyne; J J de la Rosette
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

7.  Mortality from benign prostatic hyperplasia: worldwide trends 1950-92.

Authors:  C La Vecchia; F Levi; F Lucchini
Journal:  J Epidemiol Community Health       Date:  1995-08       Impact factor: 3.710

8.  Annual costs of benign prostatic hyperplasia in New Zealand.

Authors:  W G Scott; H M Scott
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

9.  BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER IN AFRICANS AND AFRICANS IN THE DIASPORA.

Authors:  E D Yeboah; Ann W Hsing
Journal:  J West Afr Coll Surg       Date:  2016 Oct-Dec

Review 10.  Benign prostatic hyperplasia. Practical treatment guidelines.

Authors:  T Tammela
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.